PAMS
NGNE icon

Pictet Asset Management (Switzerland)’s Neurogene NGNE Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-39,078
Closed -$805K – 1601
2022
Q2 		$805K Sell
39,078
-89,638
-70% -$2.19M ﹤0.01% 1067
2022
Q1 		$4.84M Buy
128,716
+2
+0% +$117 0.01% 817
2021
Q4 		$12.4M Sell
128,714
-4,511
-3% -$550K 0.01% 612
2021
Q3 		$19.3M Buy
+133,225
New +$20.4M 0.02% 522

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s NGNE Position: Q3 2022 in Review

Pictet Asset Management (Switzerland) sold out of Neurogene (NGNE) in Q3 2022, closing a stake of 39,078 shares — an estimated $805K sold.

Pictet Asset Management (Switzerland) first reported a position in NGNE in Q3 2021 and held it in 4 quarters. The position peaked at $19.3M in Q3 2021. 52 funds tracked by Wall St. Rank hold NGNE as of Q3 2022.

  • Pictet Asset Management (Switzerland) reported no remaining Neurogene position as of Q3 2022 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 39,078 Neurogene shares in Q3 2022, an estimated $805K.
  • Pictet Asset Management (Switzerland) first reported a position in Neurogene in Q3 2021 and held it in 4 quarters.
  • Pictet Asset Management (Switzerland)'s Neurogene position peaked at $19.3M in Q3 2021.
  • 52 funds tracked by Wall St. Rank held Neurogene as of Q3 2022.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q3 2022, filed 14 Nov 2022.